Medesthetics

MAY-JUN 2017

MedEsthetics—business education for medical practitioners—provides the latest noninvasive cosmetic procedures, treatment trends, product and equipment reviews, legal issues and medical aesthetics industry news.

Issue link: http://medesthetics.epubxp.com/i/813546

Contents of this Issue

Navigation

Page 6 of 67

E E R IMPORTANT SAFE T Y INFORMATION APPROVED USES: Restylane ® Refyne is for mid-to-deep injec tion into the facial tissue for the correc tion of moderate to severe facial wrinkles and folds, such as nasolabial folds, in patients over the age of 21. Restylane ® Defyne is indicated for injec tion into the mid-to-deep dermis for correc tion of moderate to severe, deep facial wrinkles and folds, such as nasolabial folds, in patients over the age of 21. CONTR AINDICATIONS: Restylane Refyne and Restylane Defyne contain traces of gram-positive bac terial protein and are contraindicated for patients with allergies to such material or for patients with severe allergies that have required in-hospital treatment. They should not be used by patients with bleeding disorder s, with hyper sensitivity to amide-type local anesthetics, such as lidocaine, or by women who are pregnant or breastfeeding. POSSIBLE SIDE EFFECTS: The most commonly obser ved side ef fec ts include swelling, redness, pain, bruising, tenderness, headache, lump formation, and itching at the injec tion site. Use at the site of skin sores, pimples, rashes, hives, cysts, or infec tion should be postponed until healing is complete. These produc ts should not be injec ted into the blood vessels as it may cause vascular occlusion, infarc tion, or embolic phenomena. Use with caution in patients recently treated with anticoagulant or platelet inhibitor s to avoid bleeding and bruising. A s with all skin injec tion procedures , there is a risk of infec tion. To repor t a side ef fec t with any of the Restylane produc ts, please call Galderma L aboratories, L.P at 1-855-425-8722. Restylane Refyne and Restylane Defyne are available only through a licensed prac titioner. Complete Instruc tions for Use are available at www.RestylaneUSA .com. R e f e r e n ce s: 1 . Dat a o n f il e. 0 5DF 15 02 Clinic a l Stu dy Rep o r t . F o r t Wo r th , T X : Ga ld er ma L a b o rato rie s , L . P., 2016 . 2 . Dat a o n f il e. M A-3 241 8 Stu dy Rep o r t . F o r t Wo r th , T X : Ga ld er ma L a b o rato rie s , L . P., 2016 . 3. Restylane Ref yn e. Ins tr u c tio ns fo r Us e. F o r t Wo r th , T X : Ga l d er ma L a b o rato rie s , L . P.; 2016. 4 . Res t yla n e D ef yn e. Ins tr u c tio ns fo r Us e. F o r t Wo r th , T X : Ga ld er ma L a b o rato ries , L . P.; 2016. 5. D a t a o n f i l e. F o r t Wo r th , T X : G a l d e r m a L a b o rato ries , L . P., 2016. Ask your Galderma Account Manager about Restylane ® Refyne and Restylane ® Defyne today. © 2017 Galderma Laboratories, L.P. All trademarks are the property of their respective owners. USMP/REF/0024/0217 03/17 RE FYN Restylane ® Refyne and Restylane ® Defyne, two next-generation HA dermal fi llers 2-4 Two fl exible gels 2 Maintain natural expression in motion 1 Proven safe 3-5 Actual patient. Results unretouched. Individual results may vary. For your patients who want to look their naturally expressive best, 1 Restylane ® Refyne and Restylane ® Defyne are V R Y S I O N

Articles in this issue

Links on this page

Archives of this issue

view archives of Medesthetics - MAY-JUN 2017